The leukocyte integrin antagonist Del-1 inhibits IL-17-mediated inflammatory bone loss.

Autor: Eskan, Mehmet A1, Jotwani, Ravi2, Abe, Toshiharu3, Chmelar, Jindrich4, Lim, Jong-Hyung4, Liang, Shuang2, Ciero, Paul A2, Krauss, Jennifer L2, Li, Fenge2, Rauner, Martina5, Hofbauer, Lorenz C5, Choi, Eun Young6, Chung, Kyoung-Jin4, Hashim, Ahmed7, Curtis, Michael A7, Chavakis, Triantafyllos8, Hajishengallis, George9
Zdroj: Nature Immunology. May2012, Vol. 13 Issue 5, p465-473. 9p. 7 Graphs.
Databáze: Academic Search Ultimate